ACI to welcome Wendy Goggin, Chief Counsel for DEA, to the faculty of Controlled Substances Forum

NEW YORK - Nov. 25, 2013 - PRLog -- New York - Monday, November 25,2013

American Conference Institute (ACI) is pleased to introduce its Legal, Regulatory, & Compliance Forum on Controlled Substances, which will provide basic training in core regulatory concepts dealing with DEA-scheduled pharmaceutical products.  The conference, which takes place on January 16-17, 2014, at the Washington Plaza Hotel in Washington, DC, offers the opportunity to obtain a competitive advantage by knowing what to do when the DEA comes knocking on your door in one of its enforcement initiatives.  Wendy Goggin, Chief Counsel at DEA will be co-presenting the pre-conference workshop.  Take this unique opportunity to get some clarity about the complex regulations and guidance governing controlled substances.

“Not only is DEA actively enforcing diversion of prescription drugs, but FDA is also joining the conversation in its recent move to make many formerly schedule III narcotic painkillers schedule II,” said Leigh Leventhal, Senior Director of Legal Programs at ACI.  “The stakes could not be higher, as major pharmacies and wholesalers/distributors have been hit with staggering settlements and loss of licensure.  Moreover, DEA is looking higher up the supply chain to enforce responsible distribution, going so far as requiring manufacturers to monitor where their drugs are going, the frequency, and the quantities.”  The DEA will be coming after manufacturers, in addition to wholesalers, distributors, and pharmacies in its efforts to thwart diversion of prescription drugs.  Now is the time to prepare your compliance program.

Learn from and network with an expert faculty including, Wendy Goggin, Chief Counsel, DEA; Shana Mintz, Assistant US Attorney, DOJ; Larry Cote, Fmr. Associate Chief Counsel, Diversion and Regulatory Litigation Section, DEA; Virginia Beakes-Reade, Executive Director, Global Regulatory Policy and Intelligence, Global Regulatory Affairs, Eisai, Inc.; Pamela D. Politis, Ph.D., Senior Counsel, Commercial Business, Endo Pharmaceuticals, Inc.; Robert J. Meyer, MD, Associate Professor, Public Health Sciences Director, Virginia Center for Tranlational and Regulatory Sciences (VCTRS), University of Virginia; and the leading outside counsel regulatory experts.

More information about this event, including a full agenda, faculty list, and brochure can be accessed at

www.AmericanConference.com/ControlledSubstances

-- About American Conference Institute

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

– end –

CONTACT:

Jacob Schlan

American Conference Institute

212.352.3220
J. Schlan@americanconference.com
www.americanconference.com